EUVIMEDEUVIMED entdecken
Fallbericht

Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer

Ayumu Hosokawa, Rin Yamada, Yukiko Otsuki, Hotaka Tamura, Akiko Ichihara, Tsuyoshi Fukushima, Yoshihiro Komohara

Anticancer Research · 2025

DOI: 10.21873/anticanres.17847 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Anticancer Research, 2025. Verfasst von Ayumu Hosokawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan; ayhosoka@med.miyazaki-u.ac.jp. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Rectal Neoplasms, Microsatellite Instability, DNA Mismatch Repair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedRectal NeoplasmsMicrosatellite InstabilityDNA Mismatch RepairAntineoplastic Agents, ImmunologicalImmune Checkpoint InhibitorsHumansAgedMaleTreatment OutcomeTumor Microenvironment

Stichwörter der Autor:innen

Rectal cancermicrosatellite instability-highmismatch repair-deficientpembrolizumabtissue-resident memory T cells

Substanzen

Antibodies, Monoclonal, HumanizedpembrolizumabAntineoplastic Agents, ImmunologicalImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan; ayhosoka@med.miyazaki-u.ac.jp.
  • Department of Cell Pathology, Graduate School of Medicine, Kumamoto University, Kumamoto, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan.
  • Department of Surgery, University of Miyazaki Faculty of Medicine, Miyazaki, Japan.
  • Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Zitieren

APA

Hosokawa, A., Yamada, R., Otsuki, Y., Tamura, H., Ichihara, A., Fukushima, T., & Komohara, Y. (2025). Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17847

Vancouver

Hosokawa A, Yamada R, Otsuki Y, Tamura H, Ichihara A, Fukushima T, et al. Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17847

BibTeX
@article{Hosokawa2025,
  author = {Hosokawa, Ayumu and Yamada, Rin and Otsuki, Yukiko and Tamura, Hotaka and Ichihara, Akiko and Fukushima, Tsuyoshi and Komohara, Yoshihiro},
  title = {Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17847}
}
Kostenlos starten →